Results 31 to 40 of about 327,495 (248)

Predictors of walking capacity in peripheral arterial disease patients [PDF]

, 2013
OBJECTIVE: To estimate walking capacity in intermittent claudication patients through a prediction model based on clinical characteristics and the walking impairment questionnaire. METHODS: The sample included 133 intermittent claudication patients of
Chehuen, MR, Cucato, Gabriel, Farah, BQ, Forjaz, CL, Gobbo, LA, Ritti- Dias, RM, Souza-Barbosa, JP, Wolosker, N   +7 more
core   +2 more sources

Diabetic foot disease and oedema [PDF]

, 2013
Diabetic foot ulcers (DFUs) are common and disabling, giving rise to significant morbidity and mortality as well as worldwide socioeconomic problems. Despite treatment, DFUs readily become chronic wounds and may lead to major lower limb amputations.
Ho, TK, Leigh, RD, Tsui, J
core   +1 more source

Extracorporeal shockwave therapy for the treatment of lower limb intermittent claudication: Study protocol for a randomised controlled trial (the SHOCKWAVE 1 trial) [PDF]

, 2017
© 2017 The Author(s). Background: Peripheral arterial disease (PAD) has a population prevalence of 4.6% with intermittent claudication (IC) presenting as one of the earliest and most common symptoms.
Carradice, Daniel, Cayton, Thomas, Chetter, Ian C., Harwood, Amy, Harwood, Amy E., Smith, George, Smith, George E., Totty, Josh, Totty, Joshua P.   +8 more
core   +1 more source

Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).

Circulation, 2017
BACKGROUND Atherosclerotic peripheral artery disease affects 8% to 12% of Americans >65 years of age and is associated with a major decline in functional status, increased myocardial infarction and stroke rates, and increased risk of ischemic amputation.
E. Perin, M. Murphy, K. March, R. Bolli, J. Loughran, Phillip C. Yang, N. Leeper, R. Dalman, J. Alexander, T. Henry, J. Traverse, C. Pepine, R. Anderson, S. Berceli, J. Willerson, R. Muthupillai, Amir Gahremanpour, Ganesh Raveendran, Omaida Velasquez, J. Hare, I. Schulman, Vijaykumar S. Kasi, W. Hiatt, B. Ambale-Venkatesh, J. Lima, Doris A Taylor, Micheline Resende, A. Gee, A. Durett, J. Bloom, Sara Richman, Patricia G'Sell, Shari Williams, Fouzia Khan, E. Ross, Michelle R Santoso, J. Goldman, Dana Leach, E. Handberg, B. Cheong, Nichole Piece, Darcy L Difede, B. Bruhn-Ding, E. Caldwell, Judy Bettencourt, D. Lai, L. Piller, Lara M. Simpson, Michelle L. Cohen, Shelly L. Sayre, Rachel W. Vojvodic, L. Moye, R. F. Ebert, R. Simari, A. Hirsch   +54 more
semanticscholar   +1 more source

A review of the potential local mechanisms by which exercise improves functional outcomes in intermittent claudication [PDF]

, 2015
© 2016 Elsevier Inc. All rights reserved. Background Intermittent claudication (IC) is a common condition which is associated with significant quality of life limitation.
Cayton, Thomas, Chetter, Ian, Harwood, Amy, Harwood, Amy Elizabeth, Harwood, Amy-Elizabeth, Lane, Risha, Sarvanandan, Romesh   +6 more
core   +1 more source

Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study [PDF]

, 2004
ObjectiveWhile several studies have reported on the relation of diabetes status with pancreatic cancer risk, the predictive value of this disorder for other malignancies is unclear.
A Czyzyk, A Sasaki, AB Lowenfels, AB Lowenfels, Anon, B Armstrong, B Balkau, BA O?Mara, BA O?Mara, C Vecchia LA, DD Reid, DD Reid, DR Cox, E Breeze, E Freund, E Ohmura, E Tabor, F Vegt de, G Davey Smith, G Davey Smith, G Davey Smith, G Davey Smith, G Davey Smith, G Rose, G. David. Batty, GA Rose, GD Batty, GD Batty, GD Batty, GD Batty, GD Batty, George Davey Smith, H Brenner, HO Adami, HO Adami, II Kessler, II Kessler, J Everhart, J Permert, J Permert, J Schafer, JH Fuller, JH Fuller, JH Fuller, K Steenland, L Gullo, L Wideroff, M Mori, M Ragozzino, Martin J. Shipley, MC Yu, MG Marmot, MG Marmot, MG Marmot, Michael Marmot, N Trinkler, NS Weiss, RJ Jarrett, RJ Jarrett, RZ Stolzenber-Solomon, SAS Institute Inc, SH Saydah, SM Gapstur, SS Coughlin, W Fisher, W Levine, WH Chow, Y Lin   +67 more
core   +1 more source

Impact of Femoropopliteal Drug‐Coated Balloon Use on Clinical Outcomes in Patients With Chronic Limb‐Threatening Ischemia

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Drug‐coated balloons (DCBs) for femoropopliteal (FP) lesions have demonstrated superiority over standard percutaneous transluminal angioplasty (PTA) in maintaining vessel patency. However, data on whether the good durability of DCBs translates into improved wound outcome in chronic limb‐threatening ischemia (CLTI) patients are ...
Haruya Yamane, Yosuke Hata, Osamu Iida, Yasunori Ueda, Kuniyasu Ikeoka, Taku Toyoshima, Motoki Yasunaga, Hiroaki Nohara, Akito Kawamura, Sho Nakao, Yohei Sotomi, Yasushi Sakata   +11 more
wiley   +1 more source

Physical Activity Levels in Peripheral Artery Disease Patients [PDF]

, 2019
BACKGROUND: Increases in daily physical activity levels is recommended for patients with peripheral artery disease (PAD). However, despite this recommendation, little is known about the physical activity patterns of PAD patients.
Correia, Marilia de Almeida, Cucato, Gabriel, Domingues, Wagner Jorge Ribeiro, Gerage, Aline Mendes, Oliveira, Paulo Mesquita Longano de, Palmeira, Aline Cabral, Puech-Leão, Pedro, Ritti-Dias, Raphael Mendes, Wolosker, Nelson, Zeratti, Antônio Eduardo   +9 more
core   +2 more sources

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Macrophage Efferocytosis as a Therapeutic Strategy in Intervertebral Disc Degeneration

Cell Proliferation, EarlyView.
Macrophages, integral to degenerated intervertebral discs, play a critical role in disc degeneration. By performing efferocytosis, they clear apoptotic cells. This article explores the process of efferocytosis, its molecular mechanisms, potential therapeutic implications for intervertebral disc degeneration and future strategies for targeted treatments.
Shijie Chen, Haijun Zhang, Zhaoheng Wang, Daxue Zhu, Yanhu Li, Yizhi Zhang, Dongxin Wang, Shuwei Chen, Huan Liu, Xuewen Kang   +9 more
wiley   +1 more source